Suivre
Garima Lohiya
Garima Lohiya
Postdoctoral Fellow, City of Hope
Adresse e-mail validée de coh.org
Titre
Citée par
Citée par
Année
Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy
G Lohiya, DS Katti
Carbohydrate Polymers 277, 118822, 2022
702022
Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases
DA Srinivasarao, G Lohiya, DS Katti
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (4 …, 2019
552019
A synergistic combination of niclosamide and doxorubicin as an efficacious therapy for all clinical subtypes of breast cancer
G Lohiya, DS Katti
Cancers 13 (13), 3299, 2021
172021
Mesoporous silica nanoparticle-based combination of niclosamide and doxorubicin: Effect of treatment regimens on breast cancer subtypes
G Lohiya, DS Katti
ACS Applied Bio Materials 4 (11), 7811-7824, 2021
82021
Role of physicochemical properties of protein in modulating the nanoparticle-bio interface
S Dhar, V Sood, G Lohiya, H Deivendran, DS Katti
Journal of Biomedical Nanotechnology 16 (8), 1276-1295, 2020
72020
Combination of niclosamide and doxorubicin
DS Katti, G LOHIYA
2021
Nanoparticle-based drug delivery system for niclosamide and a combination thereof
DSK G Lohiya
IN Patent 373,162, 2020
2020
Nanoparticulate formulation for diagnosis and/or treatment of cancer
DSK G Lohiya, V Sood
IN Patent App. 202,011,009,535, 2020
2020
Combination of niclosamide and doxorubicin
DSK G Lohiya
IN Patent App. 202,011,008,213, 2020
2020
Application of Nanoscale Materials for Regenerative Engineering of Musculoskeletal Tissues
A Bhattacharjee, G Lohiya, A Mahajan, M Sriram, DS Katti
Regenerative Engineering, 95-118, 2018
2018
NANOPARTICULATE FORMULATION FOR DIAGNOSIS AND/OR TREATMENT OF CANCER
DS Katti, G Lohiya, V Sood
IN Patent 463,287, 0
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–11